title: Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?
authors.affiliation: Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada.
authors.forename: Philip
authors.initials: P
authors.lastname: Jong
authors.forename: Robert
authors.initials: R
authors.lastname: McKelvie
authors.forename: Salim
authors.initials: S
authors.lastname: Yusuf
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013318:Stroke Volume; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors